ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,793.30
1.44%
S&P ASX All Technology
3,068.10
1.62%
Brent Oil
83.49
0.02%
US Dollar vs AUD
1.51554
0.38%
Bitcoin
64,223.10
1.67%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Kali Inc (CE) (KALY)

  7. Kali Inc (CE) (KALY) News

KALY

Kali (CE) (KALY)

Kali Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:KALY
DateTimeSourceHeadlineSymbolCompany
07/05/202103:17InvestorsHub NewsWirePAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership HighlightsUSOTC:KALYKali Inc (CE)
06/05/202103:30InvestorsHub NewsWirePAOG 2021 CBD Nutraceuticals Rollout Preview This Friday To Include ALKM and USMJ Partnership UpdatesUSOTC:KALYKali Inc (CE)
04/05/202105:22InvestorsHub NewsWirePAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This FridayUSOTC:KALYKali Inc (CE)
13/04/202123:35InvestorsHub NewsWirePAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction TechnologyUSOTC:KALYKali Inc (CE)
12/04/202122:43InvestorsHub NewsWirePAOG Signals BUY - CBD Pharma Development Backed US PatentUSOTC:KALYKali Inc (CE)
08/04/202122:57InvestorsHub NewsWirePAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On TrackUSOTC:KALYKali Inc (CE)
17/03/202100:17InvestorsHub NewsWirePAOG Targets September 2021 To Introduce CBD Nutraceuticals To Market Co-Packed By ALKM and Marketed Through USMJUSOTC:KALYKali Inc (CE)
11/03/202105:42InvestorsHub NewsWirePAOG Announces Save The Date For CBD Nutraceuticals Expansion UpdateUSOTC:KALYKali Inc (CE)
09/03/202103:32InvestorsHub NewsWirePAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment MarketUSOTC:KALYKali Inc (CE)
04/02/202100:37InvestorsHub Cannabis NewsWirePAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation SubsidiaryUSOTC:KALYKali Inc (CE)
04/02/202100:37InvestorsHub NewsWirePAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation SubsidiaryUSOTC:KALYKali Inc (CE)
28/01/202101:18InvestorsHub Cannabis NewsWirePAOG Takes Next Step To Produce Cannabis NutraceuticalsUSOTC:KALYKali Inc (CE)
28/01/202101:18InvestorsHub NewsWirePAOG Takes Next Step To Produce Cannabis NutraceuticalsUSOTC:KALYKali Inc (CE)
21/01/202101:52InvestorsHub Cannabis NewsWirePURA In Partnership With PAOG and ALKM Prepare For Biden Bull Cannabis MarketUSOTC:KALYKali Inc (CE)
21/01/202101:52InvestorsHub NewsWirePURA In Partnership With PAOG and ALKM Prepare For Biden Bull Cannabis MarketUSOTC:KALYKali Inc (CE)
14/01/202103:22InvestorsHub NewsWirePAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update TomorrowUSOTC:KALYKali Inc (CE)
12/01/202103:10InvestorsHub NewsWirePAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2...USOTC:KALYKali Inc (CE)
23/12/202003:57InvestorsHub NewsWirePAOG Expects To Report First Post Acquisition Revenue In Q4 2020USOTC:KALYKali Inc (CE)
19/12/202001:10InvestorsHub NewsWirePAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product LineUSOTC:KALYKali Inc (CE)
19/12/202001:10InvestorsHub Cannabis NewsWirePAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product LineUSOTC:KALYKali Inc (CE)
18/12/202004:34InvestorsHub Cannabis NewsWirePAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care SolutionUSOTC:KALYKali Inc (CE)
18/12/202004:34InvestorsHub NewsWirePAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care SolutionUSOTC:KALYKali Inc (CE)
18/11/202001:41InvestorsHub NewsWirePAOG Publishes Q3 RPT Including PURA And KALY Acquisitions - Now One Key Step Closer To Dividend DistributionUSOTC:KALYKali Inc (CE)
24/10/202001:24InvestorsHub NewsWirePAOG Signs Clinical Research Organization (CRO) to Advance Respiratory Cannabis Treatment Through Regulatory ApprovalUSOTC:KALYKali Inc (CE)
22/10/202000:59InvestorsHub NewsWirePAOG Cannabis Drug Company Trends Bullish - $0.01 Breakout On Horizon?USOTC:KALYKali Inc (CE)
17/10/202004:46InvestorsHub NewsWirePAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp AwarenessUSOTC:KALYKali Inc (CE)
16/10/202000:44InvestorsHub NewsWirePAOG Releases Cannabis Drug Development UpdateUSOTC:KALYKali Inc (CE)
06/10/202002:24InvestorsHub Cannabis NewsWirePAOG Taps Canopy Growth And Altria ResourceUSOTC:KALYKali Inc (CE)
06/10/202002:24InvestorsHub NewsWirePAOG Taps Canopy Growth And Altria ResourceUSOTC:KALYKali Inc (CE)
01/10/202000:20InvestorsHub NewsWirePAOG Cannabis Pharmaceutical Research Initiative Gains New TractionUSOTC:KALYKali Inc (CE)
 Showing the most relevant articles for your search:USOTC:KALY

Your Recent History

SPI
SP500
S&P 500
ASX
AMP
AMP
NYSE
JPM
JP Morgan Chase
ASX
WDC
Westfield
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
ASX
ANZ
Australia And New Zealan...
FX
AUDJPY
AUD vs Yen
ASX
MQG
Macquarie
ASX
XTO
S&P ASX 100
FX
GBPAUD
Sterling vs AUD
ASX
QBE
QBE Insurance
NYSE
VZ
Verizon Communications
PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
ASX
ORG
Origin Energy
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved